Allergan Revenue, Profits - AGN Annual Income Statement

Add to My Stocks
$188.03 $1.96 (1.05%) AGN stock closing price Sep 19, 2018 (Closing)

Fundamental analysis of AGN stock involves analyzing its financial statements, apart from checking the Allergan stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 14.57B to 15.94B and how operating and non operating activities have impacted the AGN stock. Along with Allergan assets and Allergan free cash flow, Allergan profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-4.13B and the 2017 revenue is $15.94B.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Allergan Revenues or Net Sales
15.94B14.57B15.07B13.06B8.68B5.91B4.58B3.57B2.79B2.54B
Cost Of Goods Sold (COGS)2.17B1.86B4.81B6.3B4.69B3.39B2.56B2B1.6B1.5B
Allergan Gross Profit
13.77B12.71B10.26B6.76B3.99B2.52B2.02B1.57B1.2B1.03B
Research & Development Expense3.55B3.32B2.87B1.51B616.9M401.8M295.4M296.1M197.3M170.12M
Selling General & Admin Expense8.94B4.75B4.95B3.92B2.95B1.32B833.6M786.9M522.4M423.73M
Income Before Depreciation Depletion Amortization1.28B4.64B2.44B1.33B419.49M801.89M890.49M485.4M476.49M438.81M
Depreciation Depletion Amortization7.2B6.47B5.45B2.6B842.7M481.1M354.3M180M92.6M80.69M
Non Operating Income-3.37B289.1M-222.4M-32.6M24.6M41M1.6M29.3M12.9M28.36M
Interest Expense1.1B1.3B1.19B411.8M239.8M116.7M81.8M84.1M34.2M28.18M
Allergan Pretax Income
-10.39B-2.83B-4.43B-1.71B-638.4M245.1M456M250.6M362.6M358.31M
Provision for Income Taxes-6.67B-1.9B-1.56B-81.9M112.7M146.8M196.9M67.3M140.6M119.93M
MinorityInterest6.6M6.1M4.2M--0.7M1M-1.8M-1.1M--
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-3.72B-935M-2.87B-1.63B-751.1M98.3M259.1M183.3M222M238.37M
Extraordinary Items & Discontinued Operations-402.9M15.91B6.79B-------
Allergan Profit/ Loss (Net Income)
-4.13B14.97B3.92B-1.63B-750.4M97.3M260.9M184.4M222M238.37M
Average Shares used to compute Diluted EPS333.8M384.9M367.8M219.7M142.3M128.4M126.5M124.2M116.4M117.72M
Average Shares used to compute Basic EPS333.8M384.9M367.8M219.7M142.3M125.8M124.5M124.2M116.4M117.72M
Income Before Nonrecurring Items5.81B5.48B5.19B3.11B1.37B769.9M603.8M402.2M354.3M233.53M
Income from Nonrecurring Items-9.53B-6.42B-8.06B-4.74B-2.12B-672.6M-342.9M-217.8M-132.3M4.85M
Allergan Earnings Per Share Basic Net
-13.1938.1810.01-7.42-5.270.772.101.481.962.09
Allergan Earnings Per Share Diluted Net
-13.1938.1810.01-7.42-5.270.762.061.481.962.09
EPS Diluted Before Nonrecurring Items16.3513.5113.4313.989.506.004.773.243.042.05
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common2.800.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on Allergan stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $15.94B for this year of 2017. Our Allergan revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. AGN stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the AGN income statement, one can check the Allergan historical stock prices to check how the price has moved with time.

Allergan Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
3.95
Dividend Yield
1.51%